Gary Harton


Gary Harton, COO for US, Igenomix

Following 20+ years in both laboratory and clinical management in the IVF field, Dr. Gary Harton began his commercial career performing business development roles with two companies prominent in reproductive genetics. He has been involved in a number of exciting breakthroughs in the field of reproductive genetics including the first clinical PGD test for an autosomal dominant disease (Marfan syndrome), the first PGD case for spinal muscular atrophy (SMA), and the introduction of non-disclosing preimplantation genetic testing for Huntington disease. In addition, Dr. Harton has served on a number of international committees including the ESHRE PGD Consortium as well as the Steering Committee for External Quality Assessment through UK NEQAS.

Dr. Harton graduated from James Madison University in Harrisonburg, VA and completed his PhD work at the University of Kent, Canterbury, UK in Professor Darren Griffin’s department. He has numerous peer reviewed articles, abstracts and book chapters, and is certified by the American Board of Bioanalysis (ABB), is a member of American Society for Reproductive Medicine (ASRM), the European Society of Human Reproduction and Embryology (ESHRE), Preimplantation Genetic Diagnosis International Society and is an Honorary Senior Lecturer at the University of Kent. Dr. Harton has been an invited speaker all over the world and is frequently invited to lecture/teach students and professionals alike.

Listen to the interview with Gary (published January 2018) . https://mendelspod.com/podcasts/global-business-reproductive-genetic-tes...



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup